188 material Form 8-K filings that 175 companies we cover made with the SEC in April 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Saia's Executive Vice President and Chief Financial Officer, Douglas Col, plans to retire after 10 years with the company, including the last four as CFO. He will remain in the role until a successor is named and will stay on as an advisor through year-end to support the transition. The change is a senior finance leadership transition, though the filing contains no financial results or new guidance.
Douglas Col informed Saia of his retirement plans on April 23, 2024, after 10 years of service
Col will continue as CFO until the company names a successor and will serve as an advisor through year-end
Company announced the retirement in a press release dated April 26, 2024 (Exhibit 99.1)
Eastern Bankshares reported first-quarter 2024 net income of $38.6 million, or $0.24 per diluted share, on April 25, 2024. Total revenue was $157.6 million, down from $160.0 million in the prior quarter, while per-share profit from continuing operations rose from $0.19. Chief Financial Officer James Fitzgerald will retire once a successor is appointed, and the company has begun a search, which adds a leadership transition for shareholders to track.
Net income $38.6 million, or $0.24 per diluted share; operating EPS $0.23 vs. $0.10 in the prior quarter
Net interest income fell $3.4 million to $129.9 million; noninterest expense fell $19.8 million to $101.2 million
CFO James Fitzgerald notified the company on April 24, 2024 of his retirement; he will stay until a successor is named
Quarterly dividend of $0.11 per share payable June 14, 2024; merger with Cambridge Bancorp approved by shareholders on February 28, 2024, expected to close early in Q3 2024 pending regulatory approvals
Bio-Rad Laboratories' Executive Vice President and Chief Operating Officer, Dr. Andrew Last, notified the company on April 10, 2024 that he plans to retire by early September 2024. He will stay in his current role while Bio-Rad searches for a successor, which the company says is intended to ensure a smooth transition.
Dr. Andrew Last, EVP and Chief Operating Officer, intends to retire by early September 2024
Dr. Last will remain in his current position while the company searches for a successor
Dr. Last joined Bio-Rad in April 2019; CEO Norman Schwartz credited him with cost structure, core process and supply chain improvements
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.